Anti-tax interacting protein-1 (TIP-1) monoclonal antibody targets human cancers

Autor: Jalen Scott, Richard Laforest, Buck E. Rogers, Walter J. Akers, Heping Yan, Vaishali Kapoor, Hua Li, Dinesh Thotala, Dennis E. Hallahan, Kim Hoang Nguyen
Rok vydání: 2016
Předmět:
0301 basic medicine
Pathology
medicine.medical_treatment
TIP-1
Epitope
Mice
0302 clinical medicine
Antineoplastic Agents
Immunological

Neoplasms
Antibody-dependent cell-mediated cytotoxicity
Mice
Inbred BALB C

biology
Indium Radioisotopes
Intracellular Signaling Peptides and Proteins
Antibodies
Monoclonal

3. Good health
Oncology
030220 oncology & carcinogenesis
Radioimmunotherapy
Female
Antibody
in vivo imaging
Research Paper
medicine.medical_specialty
Single Photon Emission Computed Tomography Computed Tomography
medicine.drug_class
Mice
Nude

Enzyme-Linked Immunosorbent Assay
Monoclonal antibody
03 medical and health sciences
In vivo
Antigens
Neoplasm

Cell Line
Tumor

medicine
Animals
Humans
radiation-inducible
business.industry
Cancer
medicine.disease
Molecular biology
Xenograft Model Antitumor Assays
Mice
Inbred C57BL

030104 developmental biology
monoclonal antibody
Cancer cell
biology.protein
business
Epitope Mapping
Zdroj: Oncotarget
ISSN: 1949-2553
Popis: Radiation-inducible neo-antigens are proteins expressed on cancer cell surface after exposure to ionizing radiation (IR). These neo-antigens provide opportunities to specifically target cancers while sparing normal tissues. Tax interacting protein-1 (TIP-1) is induced by irradiation and is translocated to the surface of cancer cells. We have developed a monoclonal antibody, 2C6F3, against TIP-1. Epitope mapping revealed that 2C6F3 binds to the QPVTAVVQRV epitope of the TIP-1 protein. 2C6F3 binds to the surface of lung cancer (A549, LLC) and glioma (D54, GL261) cell lines. 2C6F3 binds specifically to TIP-1 and ELISA analysis showed that unconjugated 2C6F3 efficiently blocked binding of radiolabeled 2C6F3 to purified TIP-1 protein. To study in vivo tumor binding, we injected near infrared (NIR) fluorochrome-conjugated 2C6F3 via tail vein in mice bearing subcutaneous LLC and GL261 heterotopic tumors. The NIR images indicated that 2C6F3 bound specifically to irradiated LLC and GL261 tumors, with little or no binding in un-irradiated tumors. We also determined the specificity of 2C6F3 to bind tumors in vivo using SPECT/CT imaging. 2C6F3 was conjugated with diethylene triamine penta acetic acid (DTPA) chelator and radiolabeled with 111Indium (111In). SPECT/CT imaging revealed that 111In-2C6F3 bound more to the irradiated LLC tumors compared to un-irradiated tumors. Furthermore, injection of DTPA-2C6F3 labeled with the therapeutic radioisotope, 90Y, (90Y-DTPA-2C6F3) significantly delayed LLC tumor growth. 2C6F3 mediated antibody dependent cell-mediated cytotoxicity (ADCC) and antibody dependent cell-mediated phagocytosis (ADCP) in vitro. In conclusion, the monoclonal antibody 2C6F3 binds specifically to TIP-1 on cancer and radio-immunoconjugated 2C6F3 improves tumor control.
Databáze: OpenAIRE